Inicio / Avisos / A randomised controlled trial of transforaminal endoscopic discectomy vs microdiscectomy

A randomised controlled trial of transforaminal endoscopic discectomy vs microdiscectomy

European Spine Journal

, Volume 26, Issue 3, pp 847–856

A randomised controlled trial of transforaminal endoscopic discectomy vs microdiscectomy

AuthorsJ. N. Alaistair Gibson, Ashok S. Subramanian, Chloe E. H. Scott

 

Abstract

Purpose

Transforaminal endoscopic discectomy (TED) minimises paraspinal muscle damage. The aim of this trial was to compare clinical outcomes of TED to Microdiscectomy (Micro).

Methods

143 patients, age 25–70 years and <115 kg, with single level lumbar prolapse and radiculopathy, were recruited and randomised. 70 received TED under conscious sedation and 70 Micro under general anaesthesia. Oswestry Disability Index (ODI), visual analogue scores (VAS) of back and leg pain, and Short Form Health Survey indices (SF-36) were measured preoperatively and at 3, 12 and 24 months.

Results

All outcome measures improved significantly in both groups (p < 0.001). Affected side leg pain was lower in the TED group at 2 years (1.9 ± 2.6 vs 3.5 ± 3.1, p = 0.002). Hospital stay was shorter following TED (0.7 ± 0.7 vs 1.4 ± 1.3 days, p < 0.001). Two Micro patients and five TED patients required revision giving a relative risk of revision for TED of 2.62 (95% CI 0.49–14.0).

Conclusions

Functional improvements were maintained at 2 years in both groups with less ongoing sciatica after TED. A greater revision rate after TED was offset by a more rapid recovery.

Keywords

Lumbar discectomy Microdiscectomy Transforaminal endoscopic surgery Randomised controlled trial 

Introduction

Open spinal surgery comes at a cost of approach related morbidity. The importance of reducing muscle damage, particularly to the multifidus muscle that maintains segmental stability, has become well-recognised [1]. The concept that less aggressive decompression may yield better results has led to the development of minimally invasive techniques with microdiscectomy becoming commonplace in most centres.

In 1990, Kambin highlighted the potential access to the lumbar disc via the ‘safe-working’ zone or ‘Kambin triangle’ [2]. This precipitated interest in the transforaminal approach to the disc from within the canal [3, 4, 5], as an alternative to minimally invasive central nucleotomies (blind percutaneous endoscopic, automated percutaneous and laser discectomy) that lacked evidence of efficacy [6]. The ability to safely resect disc tissue by this method from inside the disc out [7], or outside in [8, 9], has been recognised. Whether the theoretical advantages of transforaminal endoscopic (TED) surgery for symptomatic lumbar disc herniation are borne out by patient outcomes remains unclear. A systematic review has highlighted a paucity of evidence for the TED technique [9], in comparison to data now available in respect of microendoscopic approaches [10, 11]. In view of the increasing use of transforaminal approaches to the spine, there is clearly a need for high-quality randomised controlled trials (RCTs) to determine whether TED is as effective as traditional microdiscectomy.

Patients and methods

The aim of this prospective randomised controlled trial was to determine whether TED leads to equivalent, better or worse outcomes than the current ‘gold standard’ of microdiscectomy. A power sensitivity analysis suggested 140 patients were needed to detect a 10% difference in Oswestry Disability Index (ODI) improvement at 5% significance, with 80% power and 10% loss to follow-up. Ethical approval was obtained and the study protocol published (http://www.controlled-trials.com/ISRCTN11556571).

The inclusion criteria were: age 25–70, a single level prolapse with exiting and/or traversing nerve root compression and failure of conservative management (>6 weeks of physiotherapy). Exclusion criteria were: upper lumbar disc disease (L2/3 or above), previous disc prolapse, massive sequestered disc prolapse, weight >115 kg, and malignancy.

Randomisation

All patients were randomised one week before surgery to receive either TED or Micro, by an off-site secretary using a random number generating computer program (block randomisation with odd numbers to TED and evens to Micro) [12]. This individual had no other involvement with the trial.

Surgical procedures

All TED were performed using a standardised transforaminal approach and ‘outside-in’ surgical technique using the TESSYS™ system (joimax GmbH, Germany) as previously described by Gibson et al. [9]. All surgery was performed or supervised by a senior spine surgeon with 1-year prior experience of TED and 25 years of experience with Micro. Patients were treated in the lateral position with the operating table ‘broken’ at the level of the affected disc. Conscious ‘analgo-sedation’ was administered as described by Godschalx [13]. Cannulae and endoscope placements were monitored using orthogonal bi-planar imaging (AP and lateral) with an image intensifier. No intra-operative discography was performed to outline the disc (to prevent possible internal disc fragmentation). After identification of the exiting root, pedicle and disc margin, all prolapsed material was excised using endoscopic rongeurs and a powered resector (Shrill®, joimax GmbH) ensuring that both the exiting and traversing roots lay free. Haemostasis was secured using a radiofrequency probe (Vaporflex® joimax GmbH/Surgimax, UK) with ~0.02 mm penetration depth. Direct entry into the disc was avoided unless a central herniation was present. Proximal or distal disc material was accessed by angled graspers and cannula manipulation.

Microdiscectomy was performed using a standardised technique under general anaesthesia (GA). The ligamentum flavum was divided and the traversing nerve root identified and retracted under magnification (Zeiss, UK). Only prolapsed material was excised unless a fragment was herniating through the outer annulus in which case the disc was irrigated after prolapse extraction to ensure no sequestered fragments remained. Loose fragments underlying the posterior longitudinal ligament or extending into the exit foramen were cleared. A small (<0.75 cm) piece of absorbable haemostatic gelatin sponge (Spongostan™, Ferrosan, Dk) was laid against the dura. No fat graft was inserted.

Immediate postoperative rehabilitation was identical for both treatment arms with a minimum of 2 h of bed rest before mobilisation. Patients were discharged home when comfortable and at two weeks postoperatively were allowed to drive, swim and return to work. Physiotherapy was offered if stiffness was present.

Outcome assessments

Patient reported outcome measures (PROMS) were collected prior to surgery and at 3, 12 and 24 months, postoperatively. The Oswestry Disability Index (ODI, version 2a) [14] was applied and back and leg pain scored on horizontal visual analogue scales (VAS) [15]. General health was assessed using the Short Form SF-36 [16]. Patient satisfaction was assessed using Odom criteria [17]. SF-36 scores were converted into SF-6D scores [18] (a validated measure of health-related quality of life that can be used as an alternative to the EQ-5D) to calculate quality adjusted life years (QALYs) [19]. A change from baseline approach was implemented using preoperative and 2 year SF-6D scores. Life expectancy was assumed as 77.0 years for men and 81.4 years for women based on regional life expectancy (NHS Lothian region, Life Expectancy for Areas of Scotland 2008–2010). Time spent in the new health state was calculated as life expectancy minus age at surgery and was multiplied by the individual improvement in SF-6D score to calculate QALYs gained. This was discounted at a rate of 3.5% per year of life expectancy to reflect diminishing gain with age.

Work status and length of postoperative sickness absence were recorded at follow-up. Further magnetic resonance (MR) scans, reoperations and/or additional hospital admissions directly related to the same pathology were recorded.

Statistical analysis

All analyses reported are as treated. This was identical to an intention-to-treat analysis, with the exception of one patient that crossed over from TED to Micro due to video equipment failure identified during anaesthetic induction. Data were analysed using SPSS Version 19.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were plotted as histograms to assess normality. Parametric (unpaired T tests) and non-parametric (Mann–Whitney U) tests were used to assess continuous variables for significant differences between TED and Micro. Nominal categorical variables were assessed using a Chi-square or Fisher’s exact test. Relative risks were calculated for binary outcomes (repeat MR scan and revision). Repeated measures ANOVA was used to examine changes in parametric variables over the 2-year study period. A pvalue of <0.05 was considered to be statistically significant. Post hoc analysis of PROMs changes over time was performed using paired t tests. The significance level for this was set atp < 0.0125 incorporating a Bonferroni correction to correct for multiple testing.

Results

Of 160 patients with a single-level disc prolapse assessed for eligibility to this trial, 143 met the inclusion criteria, who were recruited and randomised to the two treatment arms (Fig. 1). Three patients randomised to TED did not undergo any surgery and are not included in the analysis: one opted for nerve root injection and two underwent unrelated emergency surgery for other conditions and did not return for review. An additional patient randomised to TED underwent Micro due to equipment failure on the day of surgery. This patient has been included ‘as treated’ in the Micro group, giving 70 patients in each arm.

Fig. 1

Consort diagram of patient recruitment and retention

Baseline patient characteristics are shown in Table 1. Length of anaesthesia induction and operative time were equivalent (Table 2). A single radiographic image was used for level determination in Micro, thus radiation time and dosage was less than in TED. The TED group had a significantly shorter length of hospital stay (0.7 days ± 0.7, range 0–2 vs 1.4 days ± 1.3, range 0–9, p < 0.001).

Table 1

Baseline characteristics of the two groups

TED (n = 70)

Micro (n = 70)

Comparison (pvalue)

Demographics

 Age in years (SD)

42 (9)

39 (9)

0.76*

 Age range

26–69

25–69

 Female (%)

40 (57)

30 (43)

0.09a

 Weight in kilograms (SD)

76 (17)

81 (17)

0.95*

 Weight range

45–108

45–115

 Smoker (%)

30 (43)

20 (29)

0.11a

 Median symptom duration in months (range)

18 (4–120)

15 (3–120)

0.54**

Employment status

 Employed (%)

58 (83)

58 (83)

0.32a

 Unemployed (%)

5 (7)

4 (6

 Retired (%)

4 (6)

1 (1)

 Unknown (%)

3 (4)

7 (10)

PROMs

 ODI (SD)

44 (17)

42 (15)

0.58*

 VAS Back (SD)

5.7 (2.7)

4.6 (2.7)

0.58*

 VAS Affected Leg (SD)

6.2 (2.8)

5.8 (2.6)

0.57*

 VAS Non-affected Leg (SD)

1.0 (1.8)

0.7 (1.3)

0.29**

 SF-36 PCS (SD)

34.1 (6.8)

35.7 (7.1)

0.20*

 SF-36 MCS (SD)

38.1 (13.1)

37.9 (12.4)

0.91*

Surgical level

 L3/4 (%)

0 (0)

2 (3)

0.05a

 L4/5 (%)

32 (46)

21 (30)

 L5/S1 (%)

38 (54)

47 (67)

Disc position

 Central

19 (27)

17 (24)

0.88a

 Lateral

38 (54)

39 (56)

 Foraminal

10 (14)

12 (17)

 Extraforaminal

3 (4)

2 (3)

Data are mean (standard deviation), median (range) or number (%) as stated

* Unpaired T test

** Mann–Whitney U

aChi-squared

Table 2

Surgical outcome data

TED (n = 70)

Micro (n = 70)

Comparison (pvalue)

Hospital stay in nights (SD)

0.7 (0.7)

1.4 (1.3)

<0.001**

Hospital stay range

0–2

0–9

Anaesthesia and set-up in minutes (SD)

28 (11)

29 (12)

0.81*

Incision to closure in minutes (SD)

61 (16)

65 (36)

0.94*

Radiation dose in cGy cm2 (SD)

574 (287)

40 (31)

<0.001**

Radiation time in minutes (SD)

0.98 (0.45)

0.05 (0.09)

<0.001**

Number revised by 2 years (%)

5 (7)

2 (3)

0.44***

Time to revision in weeks (SD)

46 ± 16

60 ± 1

0.02**

Means (standard deviation), number (%)

* Unpaired T test

** MannWhitney U test

*** Fisher’s exact test

PROMs

All PROMs improved significantly over the first 3 months following surgery in both groups (p < 0.001, ANOVA Table 3; Figs. 2, 3). After Micro, ODI improved significantly to 1 year (p = 0.03) and VAS on the side of primary sciatica from 1 to 2 years (p = 0.005). After TED, ODI improved significantly to 1 year (p = 0.04) and PCS from 1 to 2 years p = 0.037). The VAS ‘affected’ leg pain score at 2 years was significantly less following TED (1.9 ± 2.6) than Micro (3.5 ± 3.1, p = 0.002) (Fig. 2c). Patients were generally more satisfied after TED (p = 0.03, Fig. 2d).

Table 3

Postoperative patient-reported outcome measures

TED (n = 70)

Micro (n = 70)

Comparison (p value)

ODI

 3 months (SD)

27(18)

27 (18)

0.84**

 1 year (SD)

22 (20)

22 (19)

0.95**

 2 years (SD)

18 (17)

22 (20)

0.15**

VAS back

 3 months (SD)

3.0 (2.7)

3.1 (2.9)

0.66**

 1 year (SD)

3.1 (3.1)

3.1 (2.7)

0.67**

 2 years (SD)

2.5 (2.5)

3.0 (2.8)

0.45**

VAS affected leg

 3 months (SD)

2.8 (2.9)

3.2 (3.2)

0.45**

 1 year (SD)

2.6 (3.1)

2.7 (2.8)

0.54**

 2 years (SD)

1.9 (2.6)

3.5 (3.1)

0.001**

VAS non-affected leg

 3 months (SD)

0.3 (0.9)

0.5 (1.4)

0.04**

 1 year (SD)

0.5 (1.7)

0.7 (1.8)

0.11**

 2 years (SD)

0.6 (1.5)

0.8 (1.8)

0.43**

SF-36 PCS

 3 months (SD)

42.4 (9.6)

43.1 (8.6)

0.65*

 1 year (SD)

45.0 (10.9)

45.1 (10.8)

0.97**

 2 years (SD)

47.7 (10.6)

47.4 (10.6)

0.69**

SF-36 MCS

 3 months (SD)

44.6 (14.2)

43.7 (14.4)

0.68**

 1 year (SD)

47.9 (14.8)

44.8 (13.9)

0.13**

 2 years (SD)

49.4 (14.1)

45.2 (14.8)

0.06**

Mean (standard deviation)

ODI Oswestry Disability Index, VAS Visual Analogue Scale for pain, PCS physical component score, MCS mental component score

* Unpaired T test

** Mann–Whitney U test

Fig. 2

Patient-reported outcome measures a Oswestry Disability Index (ODI), b Visual Analogue Scale (VAS) for back pain, c VAS for leg pain, d Odom’s criteria

Fig. 3

SF-36 scores a physical component score (PCS) and b mental component score (MCS)

Complications and revisions

There were no major intra-operative or perioperative complications in either group. Two TED patients had significant headaches immediately postoperatively, possibly due to dural tears and CSF leakage. Both settled with bed rest for 12 h. Four TED patients experienced mild dysaesthesia which settled within 2–4 weeks. One Micro patient had a persistent foot drop.

The number of additional MR scans and same level revision procedures performed within 2 years of the index surgery was higher in the TED group. Repeat MR was required in 14 TED patients compared to 6 Micro (p = 0.13, Chi-squared test) giving a relative risk (RR) of repeat MR scan of 2.67 (95% CI 0.96–7.41). Additional scans were performed at a mean of 41 ± 18 weeks (range 10–78) following TED and 51 ± 8 weeks (36–59) following Micro (p = 0.104). Revision surgery was required in 5 TED patients compared to 2 Micro (p = 0.44, Fisher’s exact test) giving an RR of 2.62 (0.49–14.0). TED patients underwent revision at 12, 26, 33, 56 and 60 weeks. Four had insidious recurrence of symptoms and one suffered an acute same level herniation after violent sneezing. The two Micro patients were revised at 51 and 60 weeks without any known new ‘disc insult’.

The TED group utilised fewer physiotherapy sessions (mean 2.9 ± 4.2 vs 4.2 ± 5.9, p = 0.21) and alternative therapy sessions (mean 0.3 ± 1.4 vs 0.5 ± 1.8, p = 0.193). This was not statistically significant.

Quality of life

The SF-6D health-related quality of life measure improved significantly to 2 years in both groups (Table 4). There was no significant difference in SF-6D improvement between groups or in QALYs gained, absolute or discounted (Table 4). Preoperatively, 116/140 patients (58 TED and 58 Micro) were in employment (Table 1), 12 of whom (7 TED and 5 Micro) worked part time. Forty-two of those in work required time off preoperatively due to their disc disease (24 TED and 16 Micro, p = 0.447, Chi square). Postoperatively, patients returned to work at a median of 2 months in both groups (p = 0.89, Mann–Whitney U). There was no significant difference in postoperative work status between groups (p = 0.79, Chi square, Fig. 4). Eight patients were unable to return to work (4 TED, 4 Micro).

Table 4

Health-related quality of life

TED (n = 70)

Micro (n = 70)

Comparison (pvalue)

SF-6D

 Preoperative (SD)

0.534 (0.09)

0.531 (0.09)

0.88*

 1 year (SD)

0.666 (0.16)

0.670 (0.15)

0.97**

 2 years (SD)

0.693 (0.18)

0.689 (0.16)

0.39**

QALYs gained at 2 years: absolute (SD)

5.944 (6.6)

6.041 (7.1)

0.95*

QALYs gained at 2 years: discounted (SD)

1.640 (1.7)

1.412 (1.5)

Mean (standard deviation)

QALYs quality-adjusted life years

* Unpaired T test

** Mann–Whitney U test

Fig. 4

Return to work status. Negative changes include reduced working hours or an inability to work due to disc disease. Positive changes include an increase in working hours or re-employment

Discussion

Patient-reported outcomes following TED were not inferior to those following Micro and some were better. This supports a previous study comparing outcomes from a cohort study of TED and Micro data from the Swedish Spine Registry [20]. Pain in the affected leg was significantly better in the TED group at 2 years. This is in contrast to the findings of the 2014 Cochrane Review of all forms of minimally invasive discectomy (11 studies) that indicated that patients had less ongoing leg pain following open discectomy [21]. However, sample sizes were small and many of the studies were of questionable quality. We found no difference in back pain between treatments. Improvements in ODI at 12 months for both TED and Micro were similar to those reported in the SPORT trial following Micro [22]. Patient-reported outcomes for TED were similar to those reported by Ahn et al. [23] in their recent retrospective analysis of outcomes following endoscopic discectomy (Yeung Endoscopic Spine System technique) in young soldiers.

In this trial, only patients with non-sequestered herniations are included. Distally migrated discs are amenable to transforaminal surgery [24] but it is technically difficult. Inclusion of these patients was thought at the trial outset to potentially introduce bias. A lower age limit of 25 was selected to exclude ‘juvenile’ type prolapses which have a different natural history.

Symptom duration prior to surgery displayed a broad range. Sub-analysis of the SPORT trial [22] has indicated that patients with greater than 6 months of symptoms risk inferior results. Most of our patients reported a history of some symptoms at a mean of 2 years before surgery and we were not able to discriminate ‘acute’ symptoms with accuracy. However, symptom duration was similar in both groups. Once in contact with the surgical service, the preoperative rehabilitation regime was standardised for all patients. We cannot comment on the effect or nature of any other prior non-operative management. Following surgery, patients were referred for physiotherapy if they complained of stiffness. Alternative therapies were not prescribed, but if received, were sourced independently by the patient and may represent a possible source of bias between groups.

We recognise that anaesthetic methods differed between the treatment arms in this trial with conscious sedation rather than GA chosen for TED as a ‘patient reporting’ safeguard against nerve root injury. Although the difference in anaesthesia did not materially alter the length of the surgical procedure (the longer GA induction for the Micro group was balanced by a longer theatre ‘set-up’ time for TED) it should be accepted that a shorter ‘wake-up’ after surgery would have contributed to the reduced hospital stay noted in the TED group. This difference may not have been as pronounced if GA had been used in both groups. Radiation doses for both procedures were well within safe ranges (<3% of accepted Dose Area Product threshold of 500 Gy cm2) [25].

The site of disc prolapse was similarly distributed in both treatment arms. The transforaminal approach is particularly suited to excision of ‘far-out’ prolapse and widening of the foramen for the exiting nerve root [26]. In contrast, Micro provides easier access to the lateral recess of the canal, although possibly with greater epidural scarring [27]. Access to the L5/S1 disc during TED may be difficult if the patient’s pelvic crest is high. In this series, L5/S1 disc access was facilitated by careful patient positioning using a ‘broken’ operating table and no patient required intra-operative conversion to Micro.

Transforaminal endoscopic surgery is associated with a significant learning curve [28]. All five revisions in the TED arm of the trial were within the first two-thirds of the study. As surgical experience with TED increases and technology advances, the incidence of revision would be expected to decline.

The combined rate of revision surgery at 5% was within that expected from most reported studies of discectomy. Of those revised, five opted for Micro as a second operation. One patient chose to have repeat TED achieving a good outcome. The reported absence of scarring at revision of TED [29] has important implications for longer-term outcomes in terms of the ease of revision surgery. The reduction in tissue disruption provided by the TED technique may also have important effects on outcome via a reduction in cytokine release lessening the overall inflammatory response to surgery [30]. In this trial, patients who underwent revision were included in our outcome data only up to the point of revision. This point was considered to represent their worst outcome scores as all patients improved following revision surgery. Had outcome scores subsequent to revision procedures been included this may have falsely improved 1 and 2 year results. On this basis, we found no significant difference in quality of life improvement between the treatment arms at 2 years.

Weaknesses of this study include the non-blinded nature of the trial. Both surgeon and patient were aware of their treatment and the senior surgeon acknowledges a specific interest in endoscopy which may introduce bias. However, all outcomes were collected independently and are patient reported. The data were scrutinised by all authors. Different anaesthetic techniques were used which may favour shorter length of stay in the TED group. This was pragmatic as it was considered safer to perform TED under conscious sedation. Though length of stay was significantly shorter in the TED group, this was a secondary outcome measure and the study was not powered to detect differences therein. No record was made of any litigation pertaining to any presenting injury. Finally, data were analysed “as treated” not as “intention-to-treat”. This was considered acceptable as only one case crossed over between treatment arms and this was due to equipment failure not clinical choice. Thirteen patients (9.3%) were lost to follow-up by 2 years. This was within the 10% allowed by our power calculation and was significantly less than the 20% required by a level 1 trial.

Conclusions

Transforaminal endoscopic discectomy and microdiscectomy give comparable outcomes. A reduced length of hospital stay and less leg pain at 2 years following TED are offset by a greater requirement for repeat MR scans and revision surgery. Although a learning curve applies for this technique, the lack of requirement for general anaesthesia and a mean length of stay under 1 day makes TED an ideal technique for use in day-case units.

Compliance with ethical standards

Conflict of interest

We have no potential conflict of interest.

Check Also

Oferta Traumatólogo en Hospital Privado de Badajoz

Última actualización 10/07/17 Grupo privado hospitalario en expansión precisa incorporar para la zona de Badajoz …